The Assessment of Sleep Quality in Patients Following Valve Repair and Valve Replacement for Infective Endocarditis : A Retrospective Study at a Single Center

BACKGROUND The aim of this study was to measure sleep quality among patients who underwent infective endocarditis (IE) surgery and identify the risk factors involved in sleep disorders. MATERIAL AND METHODS In this study, we used actigraphy, the Pittsburgh Sleep Quality Index (PSQI), and Epworth Sleep Scale (ESS) to determine the clinical characteristics of sleep disorders in 116 patients with IE who were in rehabilitation after surgery. RESULTS Our results showed that 46 (39.7%) patients had sleep efficiency over 85%, while 70 (60.3%) patients had sleep efficiency below 85%. The correlation analysis showed that sleep efficiency was related to the duration of the disease, with a longer duration leading to lower sleep efficiency (P=0.031). The sleep efficiency of patients with IE following surgery was also affected by alcohol consumption; however, surprisingly, patients with "heavy" alcohol consumption had higher sleep efficiency (P=0.030). We found a significant correlation between sleep efficiency and postoperative interleukin-6 (IL) levels, C-reactive protein (CRP) levels, and preoperative erythrocyte sedimentation rate (P<0.05). No significant correlation was found between brain natriuretic peptide levels and sleep efficiency, PSQI score, or ESS score. Postoperative hemoglobin (Hb) level was associated with sleep efficiency (R=0.194, P=0.036), but there was no statistically significant correlation between the PSQI and ESS scores. Postoperative alanine transaminase (ALT) showed a significant negative correlation with sleep efficiency (R=-0.27, P=0.003). CONCLUSIONS We found a high prevalence of sleep disorders in patients with IE along with an increase in inflammatory factors, including postoperative IL-6, CRP, ALT, and Hb levels.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:27

Enthalten in:

Medical science monitor : international medical journal of experimental and clinical research - 27(2021) vom: 26. Aug., Seite e930596

Sprache:

Englisch

Beteiligte Personen:

Hu, Xiang-Ming [VerfasserIn]
Wei, Wen-Ting [VerfasserIn]
Huang, De-Yi [VerfasserIn]
Lin, Cai-Di [VerfasserIn]
Lu, Fen [VerfasserIn]
Li, Xiao-Ming [VerfasserIn]
Liao, Huo-Sheng [VerfasserIn]
Yu, Zhi-Hong [VerfasserIn]
Weng, Xiao-Ping [VerfasserIn]
Wang, Shi-Bin [VerfasserIn]
Hou, Cai-Lan [VerfasserIn]
Jia, Fu-Jun [VerfasserIn]

Links:

Volltext

Themen:

Clinical Trial
Journal Article

Anmerkungen:

Date Completed 06.09.2021

Date Revised 15.09.2021

published: Electronic

Citation Status MEDLINE

doi:

10.12659/MSM.930596

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329769618